Respiratory failure & ventilation

Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism

J Crit CarePublished Case-control study

Authors' conclusion

We show that the procoagulant state of PBMC could aid in early detection of PE in COVID-19 ICU patients.

Study context

Population
Severe COVID-19 ICU patients
Participants
20 vs 15
Comparison
Pulmonary emboli (PE) vs Controls
  • PEn = 20
  • Controlsn = 15reference
Outcome
Procoagulant properties of peripheral blood mononuclear cells (PBMC) (modified fibrin generation time, MC-FGT) related to occurrence of PE
Methodological detailsICU biobank, functional bioassay
  • ICU biobank
  • Functional bioassay

Main finding

As reported in the abstract

MC-FGT
  • MC-FGT levels highest in samples taken closest to PE detection, similar to the ETCO2 - PaCO2 gradient

Observational data: associations, not effects.

Further findings

MC-FGT and ETCO2 - PaCO2 gradient (patients without proven PE)

Peak MC-FGT relates to an increase in ETCO2 - PaCO2 gradient

Tissue factor (TF) expression on monocyte subsets

Non-classical, CD16 positive monocytes identified as the subset with increased TF expression

Original publication

Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism. J Crit Care. Published 16 November 2023. doi:10.1016/j.jcrc.2023.154463

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.